These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9315291

  • 1. Developmental study of hepatic glutamine synthetase in a mouse model of congenital hyperammonemia.
    Skarpetas A, Mawal Y, Qureshi IA.
    Biochem Mol Biol Int; 1997 Sep; 43(1):133-9. PubMed ID: 9315291
    [Abstract] [Full Text] [Related]

  • 2. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L, Qureshi IA, Butterworth RF.
    Biochem Pharmacol; 1993 Jan 07; 45(1):137-46. PubMed ID: 8424807
    [Abstract] [Full Text] [Related]

  • 3. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Gushiken T, Yoshimura N, Saheki T.
    Biochem Int; 1985 Nov 07; 11(5):637-43. PubMed ID: 4091843
    [Abstract] [Full Text] [Related]

  • 4. Restoration of hepatic cytochrome c oxidase activity and expression with acetyl-L-carnitine treatment in spf mice with an ornithine transcarbamylase deficiency.
    Mawal YR, Rama Rao KV, Qureshi IA.
    Biochem Pharmacol; 1998 Jun 01; 55(11):1853-60. PubMed ID: 9714304
    [Abstract] [Full Text] [Related]

  • 5. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice.
    Ratnakumari L, Qureshi IA, Butterworth RF.
    Biochem Biophys Res Commun; 1992 Apr 30; 184(2):746-51. PubMed ID: 1575747
    [Abstract] [Full Text] [Related]

  • 6. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L, Qureshi IA, Butterworth RF.
    Metabolism; 1993 Aug 30; 42(8):1039-46. PubMed ID: 8102193
    [Abstract] [Full Text] [Related]

  • 7. Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine.
    Rao KV, Qureshi IA.
    Neuropharmacology; 1999 Mar 30; 38(3):383-94. PubMed ID: 10219976
    [Abstract] [Full Text] [Related]

  • 8. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency.
    Ratnakumari L, Qureshi IA, Butterworth RF.
    Metab Brain Dis; 1994 Mar 30; 9(1):43-51. PubMed ID: 7914668
    [Abstract] [Full Text] [Related]

  • 9. Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
    Soria LR, Nitzahn M, De Angelis A, Khoja S, Attanasio S, Annunziata P, Palmer DJ, Ng P, Lipshutz GS, Brunetti-Pierri N.
    J Inherit Metab Dis; 2019 Nov 30; 42(6):1128-1135. PubMed ID: 30724386
    [Abstract] [Full Text] [Related]

  • 10. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP, Bendiks M, Mori M, Kominami E, Robinson MB, Ye X, Wilson JM.
    Mol Med; 1999 Apr 30; 5(4):244-53. PubMed ID: 10448647
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive characterization of ureagenesis in the spfash mouse, a model of human ornithine transcarbamylase deficiency, reveals age-dependency of ammonia detoxification.
    Allegri G, Deplazes S, Rimann N, Causton B, Scherer T, Leff JW, Diez-Fernandez C, Klimovskaia A, Fingerhut R, Krijt J, Kožich V, Nuoffer JM, Grisch-Chan HM, Thöny B, Häberle J.
    J Inherit Metab Dis; 2019 Nov 30; 42(6):1064-1076. PubMed ID: 30714172
    [Abstract] [Full Text] [Related]

  • 12. Development and inducibility of the hepatic and renal hippurate-synthesizing system in sparse-fur (spf) mutant mice with ornithine transcarbamylase deficiency.
    Qureshi IA, Lebel S, Letarte J.
    Biochem Int; 1989 Sep 30; 19(3):657-66. PubMed ID: 2818615
    [Abstract] [Full Text] [Related]

  • 13. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX, Nakajima T, Fukushige T, Kobayashi K, Seiler N, Saheki T.
    Biochim Biophys Acta; 1999 Sep 20; 1455(1):1-11. PubMed ID: 10524224
    [Abstract] [Full Text] [Related]

  • 14. Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine.
    Ratnakumari L, Qureshi IA, Maysinger D, Butterworth RF.
    J Pharmacol Exp Ther; 1995 Jul 20; 274(1):437-43. PubMed ID: 7616428
    [Abstract] [Full Text] [Related]

  • 15. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Batshaw ML, Yudkoff M, McLaughlin BA, Gorry E, Anegawa NJ, Smith IA, Hyman SL, Robinson MB.
    Gene Ther; 1995 Dec 20; 2(10):743-9. PubMed ID: 8750014
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis of ornithine transcarbamylase deficiency in spf and spf-ash mutant mice.
    Ohtake A, Takayanagi M, Yamamoto S, Kakinuma H, Nakajima H, Tatibana M, Mori M.
    J Inherit Metab Dis; 1986 Dec 20; 9(3):289-91. PubMed ID: 3099076
    [No Abstract] [Full Text] [Related]

  • 17. Complementary expression of glutamine synthetase and carbamoylphosphate synthetase I in ornithine carbamoyltransferase-deficient mouse liver (spf-ash mouse).
    Shiojiri N, Ohta T, Ogawa K, Gebhardt R.
    Histochem Cell Biol; 1997 Dec 20; 108(6):489-94. PubMed ID: 9450631
    [Abstract] [Full Text] [Related]

  • 18. Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.
    Qvartskhava N, Lang PA, Görg B, Pozdeev VI, Ortiz MP, Lang KS, Bidmon HJ, Lang E, Leibrock CB, Herebian D, Bode JG, Lang F, Häussinger D.
    Proc Natl Acad Sci U S A; 2015 Apr 28; 112(17):5521-6. PubMed ID: 25870278
    [Abstract] [Full Text] [Related]

  • 19. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
    Nelson J, Qureshi IA, Vasudevan S, Sarma DS.
    Chem Biol Interact; 1993 Oct 28; 89(1):35-47. PubMed ID: 8221965
    [Abstract] [Full Text] [Related]

  • 20. Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.
    Cavard C, Grimber G, Dubois N, Chasse JF, Bennoun M, Minet-Thuriaux M, Kamoun P, Briand P.
    Nucleic Acids Res; 1988 Mar 25; 16(5):2099-110. PubMed ID: 3162766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.